• Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


The Role of Precision Medicine in Pancreatic Cancer: Challenges for Targeted Therapy, Immune Modulating Treatment, Early Detection, and Less Invasive Operations

Wong Khaled Kyle, Qian Zhirong, Le Yi

Year : 2016| Volume: 2| Issue : 2 | Page no: 41-47

   This article has been cited by
1 Liquid biopsy in pancreatic cancer: the beginning of a new era
Dipesh Kumar Yadav,Xueli Bai,Rajesh Kumar Yadav,Alina Singh,Guogang Li,Tao Ma,Wei Chen,Tingbo Liang
Oncotarget. 2018; 9(42): 26900
[Pubmed]  [Google Scholar] [DOI]
2 The overexpression of CPR and P450 3A4 in pancreatic cancer cells changes the metabolic profile and increases the cytotoxicity and pro-apoptotic activity of acridine antitumor agent, C-1748
Barbara Borowa-Mazgaj,Anna Mrůz,Ewa Augustin,Ewa Paluszkiewicz,Zofia Mazerska
Biochemical Pharmacology. 2017; 142: 21
[Pubmed]  [Google Scholar] [DOI]
3 K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives
Vivek Asati,Debarshi Kar Mahapatra,Sanjay Kumar Bharti
European Journal of Medicinal Chemistry. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article